ECDC country visit to Norway to discuss antimicrobial resistance issues

mission report
Cite:
Citation Link

European Centre for Disease Prevention and Control. ECDC country visit to Norway to discuss
antimicrobial issues 12–16 March 2018. Stockholm: ECDC; 2019.

Copy citation to clipboard

An ECDC country visit team conducted an assessment mission during the period 12–16 March 2018 to discuss antimicrobial resistance (AMR) issues in Norway. The overall objective of the mission was to provide an observation-based assessment of the situation in Norway regarding prevention and control of AMR through prudent use of antibiotics and infection control.

Executive summary

Data from the European Antimicrobial Resistance Surveillance Network (EARS-Net) show that the proportion of AMR in bacteria from bloodstream infections in Norwegian patients is consistently below the EU/EEA average and often among the lowest in Europe. Nevertheless, although considerably below the EU/EEA average, resistance to broad-spectrum antibiotics such as third-generation cephalosporins has been increasing over the past 10 years. This is the result of  emergence of strains that produce an extended-spectrum beta-lactamase (ESBL), combined with increasing consumption of broad-spectrum antibiotics in healthcare.

All updates on antimicrobial resistance and consumption

News

Extensively drug-resistant gonorrhoea: risk of further dissemination within and across Europe

ECDC comment -

Publication

Rapid risk assessment: Outbreak of VIM-producing carbapenem-resistant Pseudomonas aeruginosa linked to medical tourism to Mexico

risk assessment -

News

Gonorrhoea: drug resistance compromises recommended treatment in Europe

news story -

Publication

The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017

surveillance report -

News

Zoonoses: antimicrobial resistance shows no signs of slowing down

press release -